EPISODE · May 13, 2025 · 50 MIN
From Research to Recovery: The Promise of TMS with Dr David Plevin - #21 - May 10, 2025
from The Neurostimulation Podcast
Exploring Cutting-Edge Neurostimulation Techniques with Dr. David PlevinIn this episode of the Neurostimulation Podcast, Dr. Michael Passmore talks with Dr. David Plevin, an accomplished psychiatrist and PhD candidate at the University of Adelaide, about his pioneering work in clinical neurostimulation. They delve into various topics, including transcranial magnetic stimulation (TMS), theta burst TMS, and electroconvulsive therapy (ECT). Dr. Plevin sheds light on his systematic reviews and research on predictors of treatment response in depression, while also sharing his unique insights on addiction psychiatry and personalized medicine. The discussion expands to explore the potential applications of neurostimulation for substance use disorders and its future in both psychiatric and non-psychiatric treatments. Tune in for a thought-provoking conversation that promises both clinical insights and philosophical reflections on the future of brain-based therapies.https://researchers.adelaide.edu.au/profile/david.plevinDr. Plevin et al's Systematic Review https://www.sciencedirect.com/science/article/pii/S3050529124000849https://www.tmsjournal.org/article/S3050-5291(24)00084-9/pdfTrial comparing standard rTMS with TBS at 80% and 120% https://pubmed.ncbi.nlm.nih.gov/34332155/00:00 Introduction to the Neurostimulation Podcast00:34 Meet Dr. David Plevin02:28 The Journey to Psychiatry and Neurostimulation04:03 Personalized Medicine and TMS04:35 The Evolution of TMS and ECT06:02 Exploring Theta Burst Stimulation13:33 Predictors of TMS Response22:13 Combining TMS with Other Treatments35:46 Addiction Psychiatry and Neurostimulation45:07 The Future of TMS and Neurostimulation47:46 Conclusion and Farewell
NOW PLAYING
From Research to Recovery: The Promise of TMS with Dr David Plevin - #21 - May 10, 2025
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m